Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Klobučar, I; Habisch, H; Klobučar, L; Trbušić, M; Pregartner, G; Berghold, A; Kostner, GM; Scharnagl, H; Madl, T; Frank, S; Degoricija, V.
Serum Levels of Adiponectin Are Strongly Associated with Lipoprotein Subclasses in Healthy Volunteers but Not in Patients with Metabolic Syndrome.
Int J Mol Sci. 2024; 25(9):
Doi: 10.3390/ijms25095050
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Frank Sasa
- Co-authors Med Uni Graz
-
Berghold Andrea
-
Habisch Hansjörg
-
Kostner Gerhard
-
Madl Tobias
-
Pregartner Gudrun
-
Scharnagl Hubert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Metabolic syndrome (MS) is a widespread disease in developed countries, accompanied, among others, by decreased adiponectin serum levels and perturbed lipoprotein metabolism. The associations between the serum levels of adiponectin and lipoproteins have been extensively studied in the past under healthy conditions, yet it remains unexplored whether the observed associations also exist in patients with MS. Therefore, in the present study, we analyzed the serum levels of lipoprotein subclasses using nuclear magnetic resonance spectroscopy and examined their associations with the serum levels of adiponectin in patients with MS in comparison with healthy volunteers (HVs). In the HVs, the serum levels of adiponectin were significantly negatively correlated with the serum levels of large buoyant-, very-low-density lipoprotein, and intermediate-density lipoprotein, as well as small dense low-density lipoprotein (LDL) and significantly positively correlated with large buoyant high-density lipoprotein (HDL). In patients with MS, however, adiponectin was only significantly correlated with the serum levels of phospholipids in total HDL and large buoyant LDL. As revealed through logistic regression and orthogonal partial least-squares discriminant analyses, high adiponectin serum levels were associated with low levels of small dense LDL and high levels of large buoyant HDL in the HVs as well as high levels of large buoyant LDL and total HDL in patients with MS. We conclude that the presence of MS weakens or abolishes the strong associations between adiponectin and the lipoprotein parameters observed in HVs and disturbs the complex interplay between adiponectin and lipoprotein metabolism.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult - administration & dosage
-
Female - administration & dosage
-
Humans - administration & dosage
-
Male - administration & dosage
-
Middle Aged - administration & dosage
-
Adiponectin - blood
-
Case-Control Studies - administration & dosage
-
Healthy Volunteers - administration & dosage
-
Lipoproteins - blood
-
Lipoproteins, HDL - blood
-
Lipoproteins, LDL - blood
-
Magnetic Resonance Spectroscopy - administration & dosage
-
Metabolic Syndrome - blood
- Find related publications in this database (Keywords)
-
adiponectin
-
lipoprotein subclasses
-
nuclear magnetic resonance spectroscopy
-
metabolic syndrome